Synthomer (SYNT) Q2 2026 TU earnings summary

Executive summary

• Strong H1 trading with significant revenue, EBITDA, and margin progress year-over-year, driven by targeted growth and cost savings.

• Trading momentum accelerated in Q2, supported by robust positioning and pricing power amid a volatile market.

• Strategic transformation continues, including non-core divestments and focus on specialty strategy.

Financial highlights

• Continuing Group volume, revenue, EBITDA, and EBITDA margin grew strongly in the first five months of 2026 compared to the prior year.

• Q1 trading was ahead of prior year, with improved Coatings & Construction Solutions and stable Adhesive Solutions offsetting slower Health & Protection and Performance Materials.

• Q2 saw period-on-period volume, margin, and EBITDA growth ahead of expectations, aided by supply chain disruptions and pre-buying.

Outlook and guidance

• Confidence in delivering year-on-year progress in 2026, underpinned by strong H1 and ongoing cost actions.

• Geopolitical volatility and uncertain end-market trends persist, prompting continued focus on customer delivery and disciplined capital allocation.

• Strategic priorities unchanged, with further non-core divestments planned to accelerate deleveraging.